US2016228614A1PendingUtilityA1

Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal

Assignee: XUENONG ZOUPriority: Jan 27, 2004Filed: Apr 14, 2016Published: Aug 11, 2016
Est. expiryJan 27, 2024(expired)· nominal 20-yr term from priority
A61F 2002/2835A61F 2310/00544A61F 2002/30199A61F 2/30767A61L 27/38A61F 2002/30677A61F 2/38A61F 2002/3093A61L 27/365A61F 2002/30225A61F 2230/0069A61F 2310/00161A61L 2300/252A61F 2002/2817A61F 2/34A61L 2300/606A61L 27/22A61F 2310/00982A61F 2002/4648A61F 2002/0086A61F 2/4644A61L 2300/222A61F 2230/0063A61L 27/54A61F 2/44A61F 2/3094A61F 2310/00976A61F 2/36A61L 2300/64A61L 27/3608A61F 2310/00341A61F 2310/00293A61F 2/28A61L 27/00A61F 2/32C12N 5/0662A61L 27/20A61F 2310/00491A61L 27/56A61L 2430/00A61L 2400/18C12N 5/0068
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Adult autologous stem cells cultured on a porous, three-dimensional tissue scaffold-implant for bone regeneration by the use of a hyaluronan and/or dexamethasone to accelerate bone healing alone or in combination with recombinant growth factors or transfected osteogenic genes. The scaffold-implant may be machined into a custom-shaped three-dimensional cell culture system for support of cell growth, reservoir for peptides, recombinant growth factors, cytokines and antineoplastic drugs in the presence of a hyaluronan and/or dexamethasone alone or in combination with growth factors or transfected osteogenic genes, to be assembled ex vivo in a tissue incubator for implantation into bone tissue.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A three-dimensional tissue scaffold-implant for supporting tissue on-growth, the scaffold-implant comprising:
 a lattice having a matrix of interconnected pores which form surfaces in three dimensions;   an inert, bio-compatible material covering the surfaces; and   at least one of a hyaluronan, dexamethasone, protein, peptide, transcript factor, cytokine, therapeutic agent, chitosan, polymer, osteogenic gene and growth factor, covering the'material.

Join the waitlist — get patent alerts

Track US2016228614A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.